Zurcher Kantonalbank (Zurich Cantonalbank) Castle Biosciences Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$39 Billion
Q2 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 12,089 shares of CSTL stock, worth $274,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,089

Previous 12,081 0.07%

Holding current value

$274,662

Previous $241,000 2.07%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$15.8 - $21.98 $126 - $175	8 Added 0.07%	12,089 $246,000
Q1 2025 May 07, 2025	SELL	$18.76 - $32.72 $29,284 - $51,075	-1,561 Reduced 11.44%	12,081 $241,000
Q4 2024 Feb 07, 2025	BUY	$26.52 - $34.67 $110,482 - $144,435	4,166 Added 43.96%	13,642 $363,000
Q3 2024 Nov 07, 2024	SELL	$17.4 - $31.47 $7,064 - $12,776	-406 Reduced 4.11%	9,476 $270,000
Q2 2024 Jul 29, 2024	BUY	$18.84 - $24.94 $17,935 - $23,742	952 Added 10.66%	9,882 $215,000
Q1 2024 Apr 25, 2024	BUY	$18.06 - $25.3 $13,328 - $18,671	738 Added 9.01%	8,930 $197,000
Q4 2023 Jan 30, 2024	BUY	$12.19 - $22.43 $17,005 - $31,289	1,395 Added 20.52%	8,192 $176,000
Q3 2023 Oct 25, 2023	BUY	$13.28 - $20.3 $38,631 - $59,052	2,909 Added 74.82%	6,797 $114,000
Q4 2022 Feb 01, 2023	SELL	$18.08 - $30.0 $650 - $1,080	-36 Reduced 0.92%	3,888 $91,000
Q3 2022 Nov 09, 2022	SELL	$22.51 - $34.32 $1,283 - $1,956	-57 Reduced 1.43%	3,924 $102,000
Q2 2022 Aug 09, 2022	SELL	$16.0 - $45.99 $3,104 - $8,922	-194 Reduced 4.65%	3,981 $87,000
Q1 2022 Apr 21, 2022	SELL	$33.17 - $46.98 $29,886 - $42,328	-901 Reduced 17.75%	4,175 $187,000
Q4 2021 Feb 01, 2022	SELL	$39.06 - $67.58 $2,929 - $5,068	-75 Reduced 1.46%	5,076 $218,000
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $962 - $1,241	-16 Reduced 0.31%	5,151 $343,000
Q2 2021 Jul 30, 2021	BUY	$50.07 - $76.78 $8,011 - $12,284	160 Added 3.2%	5,167 $379,000
Q1 2021 May 03, 2021	BUY	$58.92 - $97.33 $184,537 - $304,837	3,132 Added 167.04%	5,007 $343,000
Q3 2020 Nov 06, 2020	BUY	$38.47 - $52.03 $72,131 - $97,556	1,875 New	1,875 $96,000

Others Institutions Holding CSTL

# of Institutions

165

Shares Held

27.2M

Call Options Held

Put Options Held

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $597M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Castle Biosciences Inc Transaction History